CLO26-101: Comparison of Clinical and Pathological Tumour Staging Following CDK4/6 Inhibitor-Based Neoadjuvant
Carol-Ann Benn1,2, Amanda Banda2, Faheemah Waja2
11Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Journal of the National Comprehensive Cancer Network : JNCCN
|April 29, 2026
Abstract
No abstract available in PubMed .

